Investigational Clinical Trials for Lung Cancer

Lung cancer clinical trials study investigational medications alone, or in combination with other study medications, or standard of care therapy.

Lung cancer occurs when cells inside the lung grow abnormally. As more cells grow, they start to form a tumor and may spread to other areas in the body. There are two main types of lung cancer:

Non-small cell lung cancers (NSCLC); about 80% to 85%
Small cell lung cancer (SCLC); about 10% to 15%

Depending on the stage of your cancer and other factors, treatment options may include surgery, radiotherapy, chemotherapy, or palliative care.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Resources for patients

For help understanding clinical trial listings and for other resources, visit the Patient Resources section.

Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.

Learn more